SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-07-000004
Filing Date
2007-01-19
Accepted
2007-01-19 15:51:22
Documents
4
Period of Report
2007-01-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR LETTER CTIC othereventctic.htm 8-K 25159
2 DOR CTIC PRESS RELEASE-011707 cticpressrelease.htm EX-99.1 21468
3 CTICLETTER 011707 cticletter.htm EX-10.1 37897
4 CTICLETTER cticletter.pdf 8-K 192177
  Complete submission text file 0000812796-07-000004.txt   351150
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 07540783
SIC: 2834 Pharmaceutical Preparations